Liver biopsy is a procedure for obtaining samples from kidney tissue for analysis. Liver biopsy is used to diagnose various liver diseases such as nonalcoholic fatty liver disease, chronic hepatitis B or C, autoimmune hepatitis, and alcoholic liver disease. Along with the diagnosis it is also used to monitor the effect of treatment and determine whether the kidney transplant is working well or not. It consists of mainly two types; percutaneous biopsy, transjugular, and laparoscopic. In a percutaneous biopsy, a needle is inserted into the kidney through the skin, while in the surgical biopsy, an incision is made in the skin near the liver to take a tissue sample for examination. Increasing prevalence of liver diseases and increasing number of biopsy procedures and diseases are the major drivers for the growth of the market. Furthermore, rising demand for new techniques for diagnosis of chronic and the need for better diagnostic and treatment methods drive the growth of the market. Major players in the developed countries lead the global market by offering new products and services to the developing countries and emerging economies. However, the high cost of diagnostic devices and instruments may hinder the market growth during the forecast period. Get a free sample copy @ https://www.marketresearchfuture.com/sample_request/5534 Intended Audience
Key Players:
Regional Analysis: The Americas liver biopsy market is expected to exhibit extensive growth owing to technological advancement in the healthcare sector and increasing number of patient population suffering from liver diseases such as alcoholic liver disease and the high healthcare spending, and increasing government support for research & development will further boost the market growth. Additionally, liver disease is one of the major cause of mortality and morbidity in the Americas, thus boosting the market growth. As per the data from (CDC), in 2016, 38,170 deaths occurred due to liver diseases in the U.S. Additionally, 6.10% of the adults were diagnosed with liver diseases in the U.S. alone. As per the World Health Organisation (WHO), about 35 million people in the world die of chronic diseases, while 46% of the mortality is due to chronic diseases. According to National statistics in the U.K, liver diseases is the fifth most common cause of death across the globe. Liver diseases are the second leading cause of mortality amongst all digestive diseases in the U.S.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
October 2021
Categories |